Have a personal or library account? Click to login
Global, Regional, and National Burden of Pancreatic Cancer, 1990–2019: Results from the Global Burden of Disease Study 2019 Cover

Global, Regional, and National Burden of Pancreatic Cancer, 1990–2019: Results from the Global Burden of Disease Study 2019

Open Access
|May 2023

References

  1. 1Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021; 71(1): 733. DOI: 10.3322/caac.21654
  2. 2Koopmann B, Omidvari AH, Lansdorp-Vogelaar I, Cahen DL, Bruno MJ, de Kok I. The impact of pancreatic cancer screening on life expectancy: A systematic review of modeling studies. Int J Cancer. 2023; 152(8): 15701580. DOI: 10.1002/ijc.34379
  3. 3McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018; 24(43): 48464861. DOI: 10.3748/wjg.v24.i43.4846
  4. 4Sun D, Cao M, Li H, He S, Chen W. Cancer burden and trends in China: A review and comparison with Japan and South Korea. Chin J Cancer Res. 2020; 32(2): 129139. DOI: 10.21147/j.issn.1000-9604.2020.02.01
  5. 5Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71(3): 209249. DOI: 10.3322/caac.21660
  6. 6Maisonneuve P. Epidemiology and burden of pancreatic cancer. Presse Med. 2019; 48(3 Pt 2): e113113e123. DOI: 10.1016/j.lpm.2019.02.030
  7. 7Fitzmaurice C, Abate D, Abbasi N, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2019; 5(12): 17491768. DOI: 10.1001/jamaoncol.2019.2996
  8. 8GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258): 12041222. DOI: 10.1016/S0140-6736(20)30925-9
  9. 9GBD 2019 Viewpoint Collaborators. Five insights from the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258): 11351159. DOI: 10.1016/S0140-6736(20)31404-5
  10. 10Tian H, Zhang K, Hui Z, et al. Global burden of non-alcoholic fatty liver disease in 204 countries and territories from 1990 to 2019. Clin Res Hepatol Gastroenterol. 2023; 47(1): 102068. DOI: 10.1016/j.clinre.2022.102068
  11. 11Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394424. DOI: 10.3322/caac.21492
  12. 12Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1): 730. DOI: 10.3322/caac.21590
  13. 13Zhu B, Wu X, Guo T, Guan N, Liu Y. Epidemiological characteristics of pancreatic cancer in China from 1990 to 2019. Cancer Control. 2021; 28: 10732748211051536. DOI: 10.1177/10732748211051536
  14. 14Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Research. 2014; 74(11): 29132921. DOI: 10.1158/0008-5472.CAN-14-0155
  15. 15Ilic M, Ilic I. Epidemiology of pancreatic cancer. World journal of gastroenterology. 2016; 22(44): 9694705. DOI: 10.3748/wjg.v22.i44.9694
  16. 16Veisani Y, Jenabi E, Khazaei S, Nematollahi S. Global incidence and mortality rates in pancreatic cancer and the association with the Human Development Index: decomposition approach. Public Health. 2018; 156: 8791. DOI: 10.1016/j.puhe.2017.12.015
  17. 17Lynch SM, Vrieling A, Lubin JH, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol. 2009; 170(4): 403413. DOI: 10.1093/aje/kwp134
  18. 18Arslan AA, Helzlsouer KJ, Kooperberg C, et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med. 2010; 170(9): 791802. DOI: 10.1001/archinternmed.2010.63
  19. 19Koyanagi YN, Ito H, Matsuo K, et al. Smoking and pancreatic cancer incidence: A pooled analysis of 10 population-based cohort studies in Japan. Cancer Epidemiol Biomarkers Prev. 2019; 28(8): 13701378. DOI: 10.1158/1055-9965.EPI-18-1327
  20. 20Molina-Montes E, Van Hoogstraten L, Gomez-Rubio P, et al. Pancreatic cancer risk in relation to lifetime smoking patterns, tobacco type, and dose-response relationships. Cancer Epidemiol Biomarkers Prev. 2020; 29(5): 10091018. DOI: 10.1158/1055-9965.EPI-19-1027
  21. 21Weissman S, Takakura K, Eibl G, Pandol SJ, Saruta M. The diverse involvement of cigarette smoking in pancreatic cancer development and prognosis. Pancreas. 2020; 49(5): 612620. DOI: 10.1097/MPA.0000000000001550
  22. 22ALHarthi S, Natto ZS, Midle JB, Gyurko R, O’Neill R, Steffensen B. Association between time since quitting smoking and periodontitis in former smokers in the National Health and Nutrition Examination Surveys (NHANES) 2009 to 2012. J Periodontol. 2019; 90(1): 1625. DOI: 10.1002/JPER.18-0183
  23. 23Ben QW, Liu J, Sun YW, Wang LF, Zou DW, Yuan YZ. Cigarette smoking and mortality in patients with pancreatic cancer: A systematic review and meta-analysis. Pancreas. 2019; 48(8): 985995. DOI: 10.1097/MPA.0000000000001383
  24. 24Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008; 393(4): 535545. DOI: 10.1007/s00423-007-0266-2
  25. 25Chen Z, Peto R, Zhou M, et al. Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. Lancet. 2015; 386(10002): 14471456. DOI: 10.1016/S0140-6736(15)00340-2
  26. 26Ben Q, Xu M, Ning X, et al. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer. 2011; 47(13): 19281937. DOI: 10.1016/j.ejca.2011.03.003
  27. 27Batabyal P, Vander Hoorn S, Christophi C, Nikfarjam M. Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies. Anns Surg Oncol. 2014; 21(7): 24532462. DOI: 10.1245/s10434-014-3625-6
  28. 28Andersen DK, Korc M, Petersen GM, et al. Diabetes, pancreatogenic diabetes, and pancreatic cancer. Diabetes. 2017; 66(5): 11031110. DOI: 10.2337/db16-1477
  29. 29Singhi AD, Koay EJ, Chari ST, Maitra A. Early detection of pancreatic cancer: Opportunities and challenges. Gastroenterology. 2019; 156(7): 20242040. DOI: 10.1053/j.gastro.2019.01.259
  30. 30Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT. Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control. 2011; 22(2): 189197. DOI: 10.1007/s10552-010-9686-3
  31. 31Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief. 2020; (360): 18.
  32. 32Preziosi G, Oben JA, Fusai G. Obesity and pancreatic cancer. Surg Oncol. 2014;23(2):6171. DOI: 10.1016/j.suronc.2014.02.003
  33. 33Jiao L, Chen L, White DL, et al. Low-fat dietary pattern and pancreatic cancer risk in the Women’s Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst. 2018; 110(1). DOI: 10.1093/jnci/djx117
DOI: https://doi.org/10.5334/aogh.4019 | Journal eISSN: 2214-9996
Language: English
Submitted on: Nov 15, 2022
Accepted on: Apr 28, 2023
Published on: May 25, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2023 Chengxia Kan, Na Liu, Kexin Zhang, Di Wu, Yunzi Liang, Weiqin Cai, Qi Jing, Fang Han, Shunjie Xing, Xiaodong Sun, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.